These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 35860239)

  • 1. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
    Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
    Front Immunol; 2022; 13():916800. PubMed ID: 35860239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
    Front Oncol; 2023; 13():972558. PubMed ID: 37064115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A five necroptosis-related lncRNA signature predicts the prognosis of bladder cancer and identifies hot or cold tumors.
    Li H; Lv Z; Liu M
    Medicine (Baltimore); 2023 Oct; 102(41):e35196. PubMed ID: 37832111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer.
    Zhao Z; Liu H; Zhou X; Fang D; Ou X; Ye J; Peng J; Xu J
    J Oncol; 2021; 2021():6718443. PubMed ID: 34790235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma.
    Zhu S; Li H; Fan Y; Tang C
    BMC Urol; 2023 Jul; 23(1):124. PubMed ID: 37479989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma.
    Yang B; Wang Y; Liu T; Zhang M; Luo T
    Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
    Tan Z; Fu S; Zuo J; Wang J; Wang H
    Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma.
    Zeng C; Yu H; Liu X; Liu Q; Jin J
    Biomed Res Int; 2022; 2022():9710540. PubMed ID: 36330457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
    Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H
    BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
    Lu H; Wu J; Liang L; Wang X; Cai H
    Front Immunol; 2022; 13():803355. PubMed ID: 35154117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
    He RQ; Huang ZG; Li TY; Wei YP; Chen G; Lin XG; Wang QY
    Cell Physiol Biochem; 2018; 50(4):1474-1495. PubMed ID: 30359990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma.
    Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L
    Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma.
    Zhang C; Li Z; Hu J; Qi F; Li X; Luo J
    J Cell Biochem; 2020 Jan; 121(1):856-866. PubMed ID: 31373406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
    Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
    Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necroptosis-associated long noncoding RNAs can predict prognosis and differentiate between cold and hot tumors in ovarian cancer.
    He YB; Fang LW; Hu D; Chen SL; Shen SY; Chen KL; Mu J; Li JY; Zhang H; Yong-Lin L; Zhang L
    Front Oncol; 2022; 12():967207. PubMed ID: 35965557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer.
    Wang J; Jiang Z; Wang K; Zheng Q; Jian J; Liu X; Chen Z; Yang R; Wang L
    Aging (Albany NY); 2024 Feb; 16(3):2812-2827. PubMed ID: 38319718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
    Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
    Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
    Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
    Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.